The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.
We are uniting efforts to reduce the development of antimicrobial resistance, invest in R&D to meet public health needs and improve access to antibiotics, vaccines and diagnostics.
Despite the ongoing challenges presented by the pandemic, the AMR Industry Alliance’s 2021 Progress Report captures efforts made by the life sciences industry to fight AMR across several domains: research and science, access, appropriate use, and manufacturing. The third iteration of this biannual report captures progress made by Alliance members between July 2019 and March 2021. Find out more below.
Our case studies provide snap-shots from across the life-sciences industry, share information on the tangible steps we are taking to invest in new research to develop new antibiotics and vaccines, prevent infection, and improve appropriate use of antibiotics.
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse The NHS will agree subscription-style deals with drugmakers for antibiotics, as the UK seeks to enco.
Geneva – July 3rd, 2024 – The AMR Industry Alliance is pleased to attend the 10th Annual World AMR Congress in the lead-up to the UN High-Level Meeting on antimicrobial resistance. The Congress wi.
The Global AMR Diary to ignite awareness and catalyze action to shape policy and saves lives GENEVA -- MAY 7, 2024 -- The Partnership to Fight Infectious Disease (PFID) and a collective.
Sepsis is a devastating condition resulting from a dysregulated immune system response to infection, which can lead to organ failure and death. Each year, sepsis affects close to 50 million people globally, of whom more than 40% are children under age 5 particularly in low- and middle-income countri.
AMR IndustryAlliance Follow
An #AMRAlliance of 100+ pharma, generics, biotech, diagnostic companies & assocs to drive & measure industry progress to curb #AntibioticResistance #AMR
Important work from @GSK and the Fleming Initiative to develop innovative interventions in the fight against #AMR.
The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.
AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org
